The diagnostic performance of neck ultrasound in follow-up of advanced stage differentiated thyroid cancer

被引:0
|
作者
Munro, Vicki [1 ]
Mustafa, Syed [2 ]
Siddiqi, Ferhan S. [1 ]
Rajaraman, Murali [4 ]
Costa, Andreu F. [3 ]
Imran, Syed Ali [1 ]
机构
[1] Dalhousie Univ, Dept Med, Div Endocrinol, 7N Victoria Bldg,1276 South Pk St, Halifax, NS B3H 2Y9, Canada
[2] Dalhousie Univ, Fac Med, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Diagnost Radiol, Halifax, NS, Canada
[4] Dalhousie Univ, Dept Radiat Oncol, Halifax, NS, Canada
关键词
Thyroid cancer; Ultrasound; Thyroglobulin; Prognosis; Recurrence; CARCINOMA; SURVEILLANCE; NODULES; DISEASE;
D O I
10.1186/s13044-024-00213-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDifferentiated thyroid cancer (DTC) requires long-term follow-up due to the risk of delayed recurrence. Follow-up surveillance involves serial neck ultrasound (US) and thyroglobulin (Tg); however, the optimal frequency and diagnostic performance of neck US outside of specialized thyroid cancer centres in higher risk patients is not well defined. We sought to evaluate the diagnostic performance of US and serial Tg in advanced stage DTC.MethodsWe retrospectively reviewed our thyroid cancer database for patients with stage III and IV DTC from 2006 to 2018, total thyroidectomy, and at least 2 years follow-up to assess recurrence rates. Those with hemi-thyroidectomy or anti-Tg antibodies were excluded. Diagnostic performance of US and Tg were assessed using a composite reference standard of follow-up imaging and pathology. All relevant US were reviewed by a blinded expert radiologist for uniformity.ResultsOf 136 included patients (91 females, mean age 58.9), 26 (19%) had recurrence of DTC over median follow-up of 6.6 years (IQR 5.3-9.3). The sensitivity and specificity of US in diagnosing cervical recurrence were 73.3% (95% CI 0.51-0.96) and 68.3% (95% CI 0.60-0.77) based on historical reports, respectively, and 80% (95% CI 0.60-1.00) and 87.8% (95% CI 0.82-0.93) based on blinded expert review, respectively. Tg had a sensitivity of 95.5% (95% CI 0.89-1.0) and specificity of 96.2% (95% CI 0.92-0.99) in detecting cervical recurrence or distant metastases. False positive US findings on historical US and subsequent review occurred in 38 (28%) and 15 (11%) patients, respectively, while 5 (3.6%) had false positive Tg results.ConclusionSerial Tg has better sensitivity and specificity than US for detecting recurrence of advanced stage DTC. Furthermore, re-interpretation of abnormal findings using structured US reporting with a subspecialized reader may improve diagnostic performance of US and improve its utility in clinical care.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Pacini, F.
    Castagna, M. G.
    Brilli, L.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 143 - 146
  • [42] Effectiveness of Peripheral Thyrotropin Receptor mRNA in Follow-Up of Differentiated Thyroid Cancer
    Mira Milas
    German F. Barbosa
    Jamie Mitchell
    Eren Berber
    Allan Siperstein
    Manjula Gupta
    Annals of Surgical Oncology, 2009, 16
  • [43] Is there an added value for whole body scan combined with stimulated thyroglobulin testing for follow-up of differentiated thyroid cancer patients?
    Giveon, Sharon
    Levy, Sigal
    Rotman-Pikielny, Pnina
    Rosenblum, Rachel Chava
    Twito, Orit
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (06) : 663 - 668
  • [44] Ultrasound and the Evaluation of Pediatric Thyroid Malignancy: Current Recommendations for Diagnosis and Follow-up
    Ogle, Sarah
    Merz, Alexa
    Parina, Ralitza
    Alsayed, Mahmoud
    Milas, Mira
    JOURNAL OF ULTRASOUND IN MEDICINE, 2018, 37 (10) : 2311 - 2324
  • [45] Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer
    Freudenthal, B.
    Williams, G. R.
    CLINICAL ONCOLOGY, 2017, 29 (05) : 325 - 328
  • [46] Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review
    Chou, Roger
    Dana, Tracy
    Mayson, Sarah E.
    Cibas, Edmund S.
    Durante, Cosimo
    Solorzano, Carmen C.
    Mandel, Susan J.
    Orloff, Lisa A.
    THYROID, 2023, 33 (04) : 420 - 427
  • [47] Parathyroid Adenomas Seen in the Clinical Follow-Up of Patients With Differentiated Thyroid Carcinoma A Diagnostic Dilemma
    Akkas, Burcu Esen
    Vural, Guelin Ucmak
    Tan, Gueler
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (02) : 70 - 71
  • [48] Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up
    Katrangi, Waddah
    Grebe, Stephan K. G.
    Algeciras-Schimnich, Alicia
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (12) : 1987 - 1994
  • [49] Current controversies in the management of neck node metastasis in differentiated thyroid cancer
    Shaha, Ashok R.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2023, 9
  • [50] Is there survival benefit from life-long follow-up after treatment for differentiated thyroid cancer?
    Garas, George
    Jarral, Omar
    Tolley, Neil
    Palazzo, Fausto
    Athanasiou, Thanos
    Zacharakis, Emmanouil
    INTERNATIONAL JOURNAL OF SURGERY, 2013, 11 (02) : 116 - 121